Who are Stargazer Pharmaceuticals's investors?

Stargazer Pharmaceuticals's investors include Pontifax Venture Capital, Canaan Partners, Novo Holdings, venBio Partners.

How much funding has Stargazer Pharmaceuticals raised?

Stargazer Pharmaceuticals has disclosed $85.5M raised across 2 rounds.

Stargazer Pharmaceuticals is headquartered in Boston, US.

Boston, US · Founded 2018 · Delaware corporation · 5 known investors

Paths you didn't know you had: your email and LinkedIn already hold routes to the Stargazer Pharmaceuticals team. We find them for you
2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Gary SternbergExecutive

Iyona Rajkomar Board directorPartner at Pontifax Venture Capital

Wende Hutton Board directorGeneral Partner at Canaan Partners

Richard Gaster Board directorManaging Partner at venBio Partners

Nanna LuneborgBoard director

Daniel CurranBoard director

John WagnerBoard director

Pontifax

SEC filings, press & company announcements

$85.5M disclosed across 2 rounds · 2018–2020

▶$28.5MraisedMay 2020 · 9 investors · Pharmaceuticals

Rule 506(b)

Officers, directors & promoters on the filing

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Who are Stargazer Pharmaceuticals's investors?: Stargazer Pharmaceuticals's investors include Pontifax Venture Capital, Canaan Partners, Novo Holdings, venBio Partners.
How much funding has Stargazer Pharmaceuticals raised?: Stargazer Pharmaceuticals has disclosed $85.5M raised across 2 rounds.
Where is Stargazer Pharmaceuticals headquartered?: Stargazer Pharmaceuticals is headquartered in Boston, US.